Saba boosts stake in Gabelli Healthcare & WellnessRx (NYSE: GRX)
Rhea-AI Filing Summary
Gabelli Healthcare & WellnessRx Trust (GRX) received an amended Schedule 13D (Amendment No. 4) reporting that Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein (together, the reporting persons) beneficially own 2,155,133 common shares of GRX. This represents 14.32% of GRX’s common shares, based on 15,050,683 shares outstanding as of 12/31/25 as disclosed in GRX’s N-CSR filed 3/9/26. The reporting persons hold shared voting and shared dispositive power over all of these shares and no sole power. Approximately $20,771,553 in aggregate was paid to acquire the reported shares, funded by investor subscription proceeds, capital appreciation, and ordinary-course margin borrowings. All transactions in the past 60 days before August 27, 2026 were executed in the open market and are detailed in an attached schedule.
Positive
- None.
Negative
- None.
Filing Explained
This Amendment No. 4 changes Items 3, 5, and 7 of the Schedule 13D, while Item 4—Purpose of Transaction—is marked “Not Applicable,” so the filing provides no stated transaction-purpose disclosure alongside its funding, ownership, and transaction history.
Key Figures
Key Terms
beneficial owner regulatory
Schedule 13D regulatory
dispositive power financial
margin account borrowings financial
subscription proceeds financial
Schedule A regulatory
FAQ
What ownership stake in GRX does Saba Capital report in this Schedule 13D/A?
How much did Saba Capital pay to acquire its GRX position?
What is the event date that triggered this GRX Schedule 13D/A amendment?
What does Amendment No. 4 to the GRX Schedule 13D change?
AI-generated analysis. How Rhea-AI works. Not financial advice.